We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380376&isReview=true
This study is massive and the market cap is tiny. They expect to be finished by end of November, going to have to see if any leaky buys appear in early Dec. For me it's a very fair gamble because the price and valuation is so low at £5.4 mil, if it's a success the market cap should reach 30-50 million so a potential 6-10 bagger against a loss of 50% if the trial is a failure so the odds are good considering the drug has already been approved and has already passed a phase 111 in Russia so there should be a pre results spike at some point.
Davy50
I've found 20 Bagger Potential *
you'll see very soon.
it's in a hot EV sector, without it EV batteries will be impossible to make.
Davy50
I've found 20 Bagger
you'll see very soon.
it's in a hot EV sector, without it EV batteries will be impossible to make.
I have a 1 million bagger opportunity send me a message on here for this wonderful opportunity. All deposits to be made to my bank in Nigeria for this once in a lifetime opportunity. Jeez you still think people on here would listen to you Earl when you keep dumping stocks for little or no gain while telling others they are 10-100 baggers it's getting very tedious.
I'll buy at 4p
too risky now
Davy50 Dm me, I'll let you know about a fantastic 100 bagger opportunity.
before I start to share with others.
you deserve to know it first
either Dm here or on twitter
The market is huge, not massive but huge but more importantly is the ratio. I mean you could have a multi billion pounds market but only get 0.1% of it. The difference with women's libido is it's apparently 10% of population 20-50 ish so the numbers could be massive. It's already approved in Russia
"Minzdrav has approved the medical prescription of Orenetide, administered through a nasal spray, to patients in the Russian Federation under the trade name 'Desirix' for the treatment of HSDD, a condition characterized by a distressing lack or loss of sexual desire. The MA was approved based on data from two Phase 1 studies, a Phase 2a study and the pivotal Phase 3 study completed in 2019, conducted in Russia, which established the safety and efficacy of Orenetide.
The approved manufacturing site for Orenetide will be operated by two reputable pharmaceutical manufacturers - Nativa and OncoTarget, with commercial production of Orenetide expected to start in Spring 2022. Ovoca Bio is currently in discussions with a number of partners to explore a potential license partnerships for sales of Orenetide on the Russian market"
Try telling that to the well researched Earl. Who doesn't think there is a market but wants to get in a 4p.
1 in 10 women need it apparently and the market has not been cracked yet. If this trial is a success then Ovb could be on the verge of something massive. The market makers have always been evil in this stock on low volumes. Not long ago you could not buy 5000 online at 8p and today they ripped off a few people selling out. Still think there will be a pre trial results spike. When they got their Russian approval even with the war on the shares touched 25p bid, now with no material changes and the trial in the latter stages the price is 6.5p bid. Given what is on the table and the current silly low valuation the price is very oversold. I'm not saying strong buy but buy due to the risks of the results of the trial but they are not due until early 2023 so there is amply opportunity for a good trade too for anybody buying in sub 7p
Who needs womens viagra? The earl is like a young Leslie Philips and womens knickers just fall off when he is around. Ding dong!
lol Earl deramping this because it's one of my biggest holdings. Knock yourself out.
Like how this drug has already passed a phase 111 trial in Russia but is now in a phase 11 trial in the far east, all endpoints were met, it was a excellent success so hopeful it should do the same on this Phase 11 trial
If it's so bad then why would you want to buy in at all ?
zero revenue, so we'll wait for Revenue Rns
in the mean time I see holders running for the hills.
Who needs women Viagra,
face on palm time
looking for 4p entry,
at the moment it's too risky
Ovb 4p buy coming?
Up again and still zero interest on the forums
Then OVB are going to muscle in on a big and growing market with not that much successful competition. It could be like the the female viagra. Market and share price is not reflecting the gamble, valuation is tiny considering. I think a big spike will happen on anticipation of good results but you might be able to play safe and trade some too.
https://www.einnews.com/pr_news/588306896/hypoactive-sexual-desire-disorder-hsdd-treatment-market-in-latam-women-to-reach-170-million-by-2027-cagr-of-3-8
That have the fewer posts on the forums. Last post here was 30th July so 10 weeks without a peep and price has certainly tanked on little selling volumes so it could bounce back strongly considering what is happening atm.
How did this not go crazy on Fridays news? Female Viagra, phase 2 studies, large participant cohort. This could be multi billion dollar news in Q1 2023. Crazy
Interesting buying action so far today on this pretty illiquid stock, wonder if news coming soon? ……btw, despite showing as a sell the latest 25k trade @ 8.46am (12p) is a buy.
News due anytime .
The licensing deal for Russia must be imminent as per the Rns. Not much stock about as keeps going NT.
I said one bag at 20p 9 more to go before war kicked of. I still maintain folk do not realise what these guys have...
Now a licence in theus would be nice:)
Few 100k buys just appeared. Great opportunity to be in early.
If you got in here. Back to 20p +...